University of California San Francisco
Displaying 1261 - 1290 of 16427
-
-
UCSF Expert Discusses Mask Mandate, Timeline on COVID-19 Endemic
-
Immune Cells Leave Fingerprints on Tumors Metastasized to the Brain, Offering Clues to Future Therapies
Using data from over 100,000 malignant and non-malignant cells from 15 human brain metastases, UCSF researchers have revealed two functional archetypes of metastatic cells across 7 different types of brain tumors, each containing both immune and non-immune cell types.
-
Drug-resistant Malaria Is Emerging in Africa. Doctors Are Worried – Yet Hopeful
-
Group Formed During Pandemic Focuses on Racial Disparities in Healthcare
-
‘I Felt As If I Failed’: Why Do Some People Feel Shame at Getting COVID?
-
UCSF Developing Tool To Identify Students Who Could Be Dyslexic in Kindergarten, First Grade
-
UCSF Dyslexia Researchers Develop Tool to Flag Early Reading Challenges
UCSF researchers have developed a digital tool to flag early reading challenges that may lead to dyslexia, and it could be in widespread use in California public schools by 2023. Governor Gavin Newsom is proposing $10 million in the state budget for the project.
-
Drug Offers New Hope to Select Patients with ALS, UCSF-CPMC Study Shows
A UCSF-led study found a new drug for ALS that shows to slow or temporarily stall the progression of ALS in a select group of patients, with three times as many patients' disease slowing compared to those who received a placebo.
-
UCSF Office of Legal Counsel Hires Two Senior Attorneys for Campus, Health Priorities
The UCSF Office of Legal Counsel is announcing the appointment of two senior attorneys to its staff to support both Campus and Health priorities. Anagha Dandekar Clifford will join as the new deputy campus counsel and chief advisor for UCSF Resiliency Strategy in late February, and Ben Durie will join as a senior counsel for Healthcare Transactions and Strategy on February 1st.
-
Experts Explain What’s Making BA.2 Omicron Subvariant More Contagious Than the Original
-
San Francisco Recommends 3rd Shot of Johnson & Johnson COVID-19 Vaccine
-
Should You Get a Second Booster Shot? Here’s What UCSF’s Dr. Bob Wachter Thinks
-
Newly Discovered Immune Cells Play a Role in Hemorrhagic Stroke
A new “atlas” of every cell in the brain’s blood vessels reveals that some strokes are caused by immune cells interacting with arteries, in a new study by UCSF researchers.
-
UCSF-led Study Uncovers Unique Stem Cell Trajectory in Lungs Damaged by COVID-19 and Pulmonary Fibrosis
A collaborative study between UCSF researchers discovered that severe lung injuries can trigger lung stem cells to undergo abnormal differentiation.
-
3 Researchers Named 2021 Fellows of American Association for the Advancement of Science
Three UC San Francisco researchers have been selected as 2021 fellows of the American Association for the Advancement of Science (AAAS), the world's largest multidisciplinary scientific society and a leading publisher of cutting-edge research through its Science family of journals. They are among 564 newly elected fellows announced Jan. 26.
-
UCSF Health Taps University of Iowa Exec as Next CEO
-
COVID Brain Fog Is Real: UCSF Neurologist Study Reveals Abnormalities in Long Haul Patients
-
Scientist Wins Prestigious Bowes Biomedical Investigator Award for Finding ‘Anti-CRISPRs’
Microbiologist Joseph Bondy-Denomy, PhD, has been selected as the 2022 William K. Bowes Jr. Biomedical Investigator for his groundbreaking discovery of a secret weapon deployed by viruses in their ancient battle against bacteria.
-
Drug Targeting Tauopathies in Mice Reveals Sex Differences in Response
UCSF researchers used multiple drug analogs to test CSF1R inhibition in transgenic mice with tauopathy, and observed suppressed biomarkers of neurodegeneration, rescued aberrant behavior, and extended survival in female mice.
-
UCSF Benioff Children’s Hospital San Francisco Becomes Second in State to Earn Top Surgery Designation
UCSF Benioff Children's Hospital San Francisco has been verified as a Level 1 Children’s Surgery Center by the American College of Surgeons.
-
Suresh Gunasekaran Tapped as Chief Executive of UCSF Health
UCSF has named Suresh Gunasekaran, MBA, as the new president and chief executive officer of UCSF Health, bringing an accomplished leader to the world-renowned health system.
-
Race-Based Prescribing for Black People with High Blood Pressure Shows No Benefit
For years, physicians have been taught to prescribe different drugs to Black people with high blood pressure. A recent UCSF study calls that into question.
-
Cerebrospinal Fluid Offers Clues to Post-COVID ‘Brain Fog’
Many patients with COVID-19 develop brain fog and other cognitive symptoms months later. Their cerebrospinal fluid may hold clues to why this is happening.
-
UCSF Infectious Disease Specialist Discusses COVID-19 Surge in Children
-
32 UCSF Researchers Named New Chan Zuckerberg Biohub Investigators
Thirty-two UCSF faculty members have been named to the second cohort of Chan Zuckerberg Biohub Investigators and will receive $1 million apiece in unrestricted funds over the next five years to pursue creative and innovative research.
-
Nose or Throat? The Best Way to Swab for At-Home COVID-19 Tests
-
‘It Just Takes a Hit on the Morale’: How a UCSF Respiratory Therapist Takes On the Omicron Surge
-
Binge Drinking Linked to First Episodes of Heart Rhythm Disorder
Binge drinking can lead to more ER visits and first episodes of a serious heart condition, new UCSF study reports.
-
Human Proteins Behind COVID-19 Infection Revealed by Innovative CRISPR Technology
In the quest for new treatments for COVID-19, a team led by UCSF researchers identified a new potential drug target that may prevent infection of human cells by SARS-CoV-2.
